Table 2. Top ten changes in UCMD vs Control.
| Gene symbol | Gene description | FC | FDR |
|---|---|---|---|
| IGFN1 | Immunoglobulin-like and fibronectin type III domain containing 1 | -8.8 | 0 |
| GADD45G | Growth arrest and DNA-damage-inducible, gamma | -4.6 | 0.0011 |
| KLHL34 | kelch-like 34 | -4.1 | 0.0011 |
| AKR1B10 | Aldo-keto reductase family 1, member B10 (aldose reductase) | -3.7 | 0.002 |
| ARRDC2 | Arrestin domain containing 2 | -4.1 | 0.0027 |
| ZMYND17 | MSS51 mitochondrial translational activator homolog | -3.3 | 0.0058 |
| ADAMTS8 | ADAM metallopeptidase with thrombospondin type 1 motif, 8 | -4.1 | 0.0071 |
| RELT | Tumor necrosis factor receptor | -3.1 | 0.01 |
| ACTN3 | Actinin alpha 3 | -3.0 | 0.01 |
| HPDL | 4-hydroxyphenylpyruvate dioxygenase-like | -3.0 | 0.01 |
| MYH8 | Myosin, heavy chain 8, skeletal muscle, perinatal | 57.7 | 0 |
| RBP4 | Retinol binding protein 4 | 19.6 | 0 |
| CIDEC | Cell death-inducing DFFA-like effector c | 11.6 | 0 |
| LGALS7 | Galectin 7 | 10.9 | 0 |
| ADIPOQ | Adiponectin | 9.6 | 0 |
| PLIN1 | Perilipin 1 | 9.4 | 0 |
| S100B | S100 calcim binding protein B | 8.0 | 0 |
| HMGCS2 | 3-hydroxy-3-m3thylglutaryl-CoA synthase 2 | 7.5 | 0 |
| HLA-DQA1 | Major histocompatibility complex, class II, DQ alpha 1 | 5.3 | 3.33E-04 |
| LEP | Leptin | 5.1 | 3.33E-04 |
FC, Fold-change; FDR, False Discovery Rate.